Evaluation report of the DMP “DM1” 2022 published

The Federal Joint Comitee (G-BA) as well as the authorising health insurance companies have published the evaluation report on the indication DM1 (Diabetes mellitus Type 1) for the year 2022.

Report DM1
Do NOT follow this link or you will be banned from the site!